Meta-analysis
Open access
Sarcopenia and Survival in Patients With Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta‐Analysis of Prognostic Association
D. Koirala
Nakendra Malla
Bivek Mishra
Ramesh Sapkota
Sahil Niraula
Kushal Bastola
Nirman Khatiwada
Manisha Gahatraj
Rijan Kafle
Medicine
Abstract
Sarcopenia, characterized by loss of skeletal muscle mass and function, has emerged as a potential prognostic biomarker in oncology. Its role in patients with head and neck squamous cell carcinoma (HNSCC) treated with immune checkpoint inhibitors (ICIs) remains inadequately defined.